Orris

Child is on Inj Meropenam , Inj Vancomycin and Inj Acyclovir for meningitis, already completed 3 days . Repeat CRP is 111mg/ dl . What could be done next

Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed

"Meningitis, Bacterial"[MeSH Terms] AND "Treatment Outcome"[MeSH Terms]

Searching the Web

pediatric bacterial meningitis repeat lumbar puncture clinical deterioration persistent fever guideline

This child needs urgent reassessment by the treating pediatric team now, preferably with pediatric infectious-disease input. A CRP of 111 mg/dL would equal 1,110 mg/L, which is exceptionally high. Please first verify the unit and result with the laboratory, since CRP is commonly reported as mg/L.
Do not change, add, or stop meropenem, vancomycin, or acyclovir based on CRP alone. The next decisions should be driven by the child’s clinical status, initial CSF findings, cultures/PCR, susceptibilities, and complications.

Immediate priorities

  1. Assess for instability or neurologic deterioration
    • Persistent fever, shock, poor perfusion, reduced consciousness, recurrent seizures, focal neurologic signs, raised intracranial pressure signs, bulging fontanelle, or respiratory compromise require PICU-level assessment.
    • Ensure adequate IV access, fluids/vasopressors if needed, glucose/electrolytes, seizure control, and monitoring.
  2. Review the microbiology today
    • Initial CSF Gram stain, culture and sensitivity, blood cultures, bacterial PCR panel, HSV PCR, and any TB/fungal testing.
    • Obtain repeat blood cultures if fever persists or there is concern for bacteremia/line infection.
    • Verify that the drugs and doses are appropriate for the child’s age, weight, renal function, organism, and CNS penetration.
    • Check renal function and arrange therapeutic monitoring for vancomycin according to local protocol.
  3. Consider repeat lumbar puncture now A repeat CSF study with cell count, glucose/protein, Gram stain, culture and relevant PCR is reasonable when there is no clear clinical improvement after 48-72 hours, persistent fever, worsening status, suspected resistance, or a resistant organism. This is not routine for every improving child, but is specifically relevant in this scenario. The WHO meningitis manual supports repeat LP in selected cases with poor response, persistent fever, or suspected drug resistance.
  4. Look actively for a complication or alternate focus Discuss urgent neuroimaging, usually contrast MRI brain if stable and available, or CT if urgent, particularly with reduced consciousness, seizures, focal signs, persistent fever/inflammation, or concern for:
    • subdural effusion/empyema
    • ventriculitis
    • hydrocephalus
    • cerebral abscess
    • venous sinus thrombosis
    • parameningeal focus such as mastoiditis/sinusitis
    Children with meningitis can develop subdural effusions, and persistent non-response should prompt a complication search.
  5. Reassess the working diagnosis
    • Is it proven bacterial meningitis, HSV encephalitis/meningoencephalitis, partially treated meningitis, TB/fungal meningitis, or another inflammatory/infectious illness?
    • Acyclovir should be continued or stopped based on the child’s encephalitic features and HSV CSF PCR/testing, in consultation with the treating specialist, not on CRP.

About CRP

CRP can lag behind the child’s clinical course. A single high or rising CRP is concerning, but it cannot by itself establish antibiotic failure. The important question is whether the child is clinically improving and whether CSF/blood cultures have cleared. Recent pediatric evidence reviews address antibiotic selection and duration, but do not support escalating therapy solely for a CRP value (2025 systematic review, PMID 40456280).
Practical message for the treating team: “Day 3 with CRP reported 111 mg/dL, please verify units; review CSF/blood cultures and sensitivities, drug doses and renal function/vancomycin monitoring; obtain repeat LP if no improvement or persistent fever; and arrange neuroimaging to exclude intracranial complications.”

Next antibiotics that can be started

Reading File
Finding Sources
Finding Sources
Searching PubMed

"Meningitis, Bacterial"[MeSH Terms] AND child AND meropenem

Searching the Web

pediatric bacterial meningitis meropenem vancomycin treatment failure antibiotic guideline repeat CSF

Do not empirically add a “next” antibiotic just because CRP is high. Meropenem plus vancomycin is already very broad CNS-directed bacterial coverage. Adding another antibiotic without identifying the organism or a complication can delay the correct intervention and increase toxicity.
At day 3 with poor response/persistent inflammation, the appropriate next step is urgent pediatric infectious-disease/PICU review, with:
  • repeat CSF testing if the child is not clinically improving: culture, Gram stain, cell count, glucose/protein, and PCR as appropriate
  • review of the original CSF and blood culture/susceptibility results
  • check whether vancomycin exposure is therapeutic and renal function is stable
  • MRI brain or urgent CT when indicated to exclude subdural empyema/effusion, ventriculitis, hydrocephalus, abscess, venous thrombosis, mastoiditis, etc.
  • search for another source such as line infection, pneumonia, urinary infection, or sepsis
Guidance supports repeat LP at 48-72 hours when the child is worsening or not improving, or resistance is suspected, rather than routine escalation of antibiotics (pediatric meningitis review).

Antibiotics depend on the result, not CRP

Examples of culture-directed changes the team may consider:
Situation identifiedPossible action by pediatric ID team
Pneumococcus susceptible to ceftriaxone/cefotaximeDe-escalate to the susceptible narrower agent, often stopping vancomycin when appropriate
Resistant pneumococcus or persistent positive CSFConfirm optimized vancomycin exposure and susceptibilities; specialist-directed regimen, sometimes with adjunctive rifampicin in selected cases
Gram-negative bacillus or ESBL organismMeropenem may already be appropriate, but repeat CSF clearance and longer treatment may be needed
PseudomonasMeropenem may cover it if susceptible, but definitive treatment must follow MIC/susceptibility results
ListeriaAmoxicillin/ampicillin is traditionally used, though meropenem has activity; management should be specialist-directed, especially in neonates
TB, fungal meningitis, scrub typhus, etc.These require entirely different pathogen-specific regimens. Adding routine antibacterials will not treat them
Brain abscess/subdural empyemaAntibiotics alone may be insufficient. Neurosurgical drainage/source control can be decisive
Acyclovir is not an antibiotic. Its continuation should be based on concern for HSV encephalitis and CSF HSV PCR, not CRP.
So the practical answer is: do not add ceftriaxone, cefotaxime, ampicillin, aminoglycoside, colistin, or rifampicin blindly on top of meropenem plus vancomycin. Obtain cultures/CSF clearance and imaging urgently, then tailor therapy. If the child has shock, worsening consciousness, seizures, or breathing difficulty, this is an immediate PICU/emergency situation.
This is a shared conversation. Sign in to Orris to start your own chat.